The Sarsia Seed Management team comes from a wide variety of backgrounds with a collective expertise which is extensive not only with respect to the various investment areas on which the fund focuses, but also with respect to best practice/effective fund administration. The team, through its association with the Fund board and the commercialization/investment cluster, has access to an extensive network of contacts including technical, industrial, academic and financial associates both nationally and internationally.
+47 90 93 28 72
Erlend brings 20 years of experience from R&D based IPR, project- and business development from Christian Michelsen Research, Forinnova and Sarsia Innovation. Has managed several turnaround processes and negotiated a large number of international contracts, licenses and trade exits. Broad board experience.
Ph.D in microbiology
+47 90 06 23 03
Øivind has over 13 years of research experience in molecular biology and fish disease, and 5 years in commercialising research based projects in biology, aqua culture, medicine and biotechnology. He has several years of managerial and board experience from position with Sarsia Innovation AS.
+47 95 27 28 39
Marit Wick has 20 years experience from financial and administrative management, as well as strategic-, organizational- and M&A management experience from private and publicly traded industrial companies within the off-shore industry, food industry, real estate and life science sector
Jon Trygve Berg
Partner, Energy and Technology
Siv. Ing., MBA, CEFA
+47 95 23 76 49
Jon bring 14 years of VC experience in technology companies. Jon sits on the board of Heimdall Power, WindSim, ISN-GreenPowerHub, Trisense, Xsens and SeaSmart. Jon is a mechanical engineer and authorised financial analyst (CEFA). He has experience as CEO from early stage start ups like GexCon and PE&C and CTO from VC backed AI/Speech technology start up NST.
Partner, Life Science Investments
+47 90 59 72 90
Farzad’s background is in preclinical and clinical research with drug development experience from US based global pharma in the US and Norway. He has 17 years of experience in commercializing medical/biotech projects from the Sarsia investment system. Farzad received his doctorate in pharmacology from the University of Edinburgh Medical School, UK and postdoctoral training from Haukeland University Hospital Bergen, Norway.